Based on available Phase 2 data, retatrutide appears to offer a promising benefit profile, particularly in terms of the magnitude of weight loss and its potential to address multiple metabolic pathways simultaneously
The Medicare GLP-1 Bridge took effect July 1, 2026, and we are seeing Medicare patients and submitting Bridge prior authorizations now, in person in Papillion or by telehealth in 16 states
The cerebellar nuclei project monosynaptic connections to the thalamus, vestibular nuclei, and inferior olive and in rodents have been shown to project to the red nucleus
While results and side effects can vary, this medication is widely recognized as one of the most innovative options available for individuals seeking structured, medically guided weight support
The injection site reaction guide explains what these superficial delivery signs look like
CFS also features unique symptoms like post-exertional malaise and cognitive issues not typically seen in obesity-related fatigue